aluates Reports

$ 0.0

Automative

Global Immunological Agents Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-8E13320

Global Immunological Agents Market Research Report 2023

BUY CHAPTERS

Global Immunological Agents Market Research Report 2024

Code: QYRE-Auto-8E13320

Report

August 2024

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

Organon

Amneal Pharmaceuticals

Apotex

Teva Pharmaceuticals

Biocon Ltd.

Bristol–Myers Squibb

Merck

CSL Behring

Sanofi

Leading Pharma

Accord Healthcare Inc.

Amgen Inc

Nabi Biopharmaceuticals

Ascend Laboratories

Camber Pharmaceuticals, Inc.

Grifols USA

JOM Pharmaceuticals

Immunological Agents Market

The global Immunological Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Immunological Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Immunological Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Immunological Agents in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Immunological Agents include Abbott, Organon, Pfizer, Sandoz, Amneal Pharmaceuticals, Apotex, Teva Pharmaceuticals, Biocon and Bristol Myers Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Immunological Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunological Agents.

Report Scope

The Immunological Agents market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunological Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immunological Agents companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Immunological Agents Market Report

Report Metric	Details
Report Name	Immunological Agents Market
Segment by Type	Antirheumatic Drugs (DMARDs) Immune Globulins Immunomodulatory Agents Immunosuppressive Agents Monoclonal Antibodies Other
Segment by Application	Hospital Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Organon, Pfizer, Sandoz, Amneal Pharmaceuticals, Apotex, Teva Pharmaceuticals, Biocon, Bristol Myers Squibb, Merck, CSL Behring, Sanofi, Leading Pharma, Accord Healthcare Inc, Amgen, Nabi Biopharmaceuticals, Ascend Laboratories, Camber Pharmaceuticals Inc, Grifols USA, JOM Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunological Agents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Immunological Agents Market report?

Ans: The main players in the Immunological Agents Market are Abbott, Organon, Pfizer, Sandoz, Amneal Pharmaceuticals, Apotex, Teva Pharmaceuticals, Biocon, Bristol Myers Squibb, Merck, CSL Behring, Sanofi, Leading Pharma, Accord Healthcare Inc, Amgen, Nabi Biopharmaceuticals, Ascend Laboratories, Camber Pharmaceuticals Inc, Grifols USA, JOM Pharmaceuticals

What are the Application segmentation covered in the Immunological Agents Market report?

Ans: The Applications covered in the Immunological Agents Market report are Hospital, Clinics, Others

What are the Type segmentation covered in the Immunological Agents Market report?

Ans: The Types covered in the Immunological Agents Market report are Antirheumatic Drugs (DMARDs), Immune Globulins, Immunomodulatory Agents, Immunosuppressive Agents, Monoclonal Antibodies, Other

Recommended Reports

Immunotherapy Markets

Vaccine & Delivery

Immune Related Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immunological Agents Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Antirheumatic Drugs (DMARDs)

1.2.3 Immune Globulins

1.2.4 Immunomodulatory Agents

1.2.5 Immunosuppressive Agents

1.2.6 Monoclonal Antibodies

1.2.7 Other

1.3 Market by Application

1.3.1 Global Immunological Agents Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immunological Agents Market Perspective (2019-2030)

2.2 Immunological Agents Growth Trends by Region

2.2.1 Global Immunological Agents Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Immunological Agents Historic Market Size by Region (2019-2024)

2.2.3 Immunological Agents Forecasted Market Size by Region (2025-2030)

2.3 Immunological Agents Market Dynamics

2.3.1 Immunological Agents Industry Trends

2.3.2 Immunological Agents Market Drivers

2.3.3 Immunological Agents Market Challenges

2.3.4 Immunological Agents Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immunological Agents Players by Revenue

3.1.1 Global Top Immunological Agents Players by Revenue (2019-2024)

3.1.2 Global Immunological Agents Revenue Market Share by Players (2019-2024)

3.2 Global Immunological Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Immunological Agents Revenue

3.4 Global Immunological Agents Market Concentration Ratio

3.4.1 Global Immunological Agents Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immunological Agents Revenue in 2023

3.5 Immunological Agents Key Players Head office and Area Served

3.6 Key Players Immunological Agents Product Solution and Service

3.7 Date of Enter into Immunological Agents Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Immunological Agents Breakdown Data by Type

4.1 Global Immunological Agents Historic Market Size by Type (2019-2024)

4.2 Global Immunological Agents Forecasted Market Size by Type (2025-2030)

5 Immunological Agents Breakdown Data by Application

5.1 Global Immunological Agents Historic Market Size by Application (2019-2024)

5.2 Global Immunological Agents Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Immunological Agents Market Size (2019-2030)

6.2 North America Immunological Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Immunological Agents Market Size by Country (2019-2024)

6.4 North America Immunological Agents Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immunological Agents Market Size (2019-2030)

7.2 Europe Immunological Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Immunological Agents Market Size by Country (2019-2024)

7.4 Europe Immunological Agents Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Immunological Agents Market Size (2019-2030)

8.2 Asia-Pacific Immunological Agents Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Immunological Agents Market Size by Region (2019-2024)

8.4 Asia-Pacific Immunological Agents Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Immunological Agents Market Size (2019-2030)

9.2 Latin America Immunological Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Immunological Agents Market Size by Country (2019-2024)

9.4 Latin America Immunological Agents Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immunological Agents Market Size (2019-2030)

10.2 Middle East & Africa Immunological Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Immunological Agents Market Size by Country (2019-2024)

10.4 Middle East & Africa Immunological Agents Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Detail

11.1.2 Abbott Business Overview

11.1.3 Abbott Immunological Agents Introduction

11.1.4 Abbott Revenue in Immunological Agents Business (2019-2024)

11.1.5 Abbott Recent Development

11.2 Organon

11.2.1 Organon Company Detail

11.2.2 Organon Business Overview

11.2.3 Organon Immunological Agents Introduction

11.2.4 Organon Revenue in Immunological Agents Business (2019-2024)

11.2.5 Organon Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Detail

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Immunological Agents Introduction

11.3.4 Pfizer Revenue in Immunological Agents Business (2019-2024)

11.3.5 Pfizer Recent Development

11.4 Sandoz

11.4.1 Sandoz Company Detail

11.4.2 Sandoz Business Overview

11.4.3 Sandoz Immunological Agents Introduction

11.4.4 Sandoz Revenue in Immunological Agents Business (2019-2024)

11.4.5 Sandoz Recent Development

11.5 Amneal Pharmaceuticals

11.5.1 Amneal Pharmaceuticals Company Detail

11.5.2 Amneal Pharmaceuticals Business Overview

11.5.3 Amneal Pharmaceuticals Immunological Agents Introduction

11.5.4 Amneal Pharmaceuticals Revenue in Immunological Agents Business (2019-2024)

11.5.5 Amneal Pharmaceuticals Recent Development

11.6 Apotex

11.6.1 Apotex Company Detail

11.6.2 Apotex Business Overview

11.6.3 Apotex Immunological Agents Introduction

11.6.4 Apotex Revenue in Immunological Agents Business (2019-2024)

11.6.5 Apotex Recent Development

11.7 Teva Pharmaceuticals

11.7.1 Teva Pharmaceuticals Company Detail

11.7.2 Teva Pharmaceuticals Business Overview

11.7.3 Teva Pharmaceuticals Immunological Agents Introduction

11.7.4 Teva Pharmaceuticals Revenue in Immunological Agents Business (2019-2024)

11.7.5 Teva Pharmaceuticals Recent Development

11.8 Biocon

11.8.1 Biocon Company Detail

11.8.2 Biocon Business Overview

11.8.3 Biocon Immunological Agents Introduction

11.8.4 Biocon Revenue in Immunological Agents Business (2019-2024)

11.8.5 Biocon Recent Development

11.9 Bristol Myers Squibb

11.9.1 Bristol Myers Squibb Company Detail

11.9.2 Bristol Myers Squibb Business Overview

11.9.3 Bristol Myers Squibb Immunological Agents Introduction

11.9.4 Bristol Myers Squibb Revenue in Immunological Agents Business (2019-2024)

11.9.5 Bristol Myers Squibb Recent Development

11.10 Merck

11.10.1 Merck Company Detail

11.10.2 Merck Business Overview

11.10.3 Merck Immunological Agents Introduction

11.10.4 Merck Revenue in Immunological Agents Business (2019-2024)

11.10.5 Merck Recent Development

11.11 CSL Behring

11.11.1 CSL Behring Company Detail

11.11.2 CSL Behring Business Overview

11.11.3 CSL Behring Immunological Agents Introduction

11.11.4 CSL Behring Revenue in Immunological Agents Business (2019-2024)

11.11.5 CSL Behring Recent Development

11.12 Sanofi

11.12.1 Sanofi Company Detail

11.12.2 Sanofi Business Overview

11.12.3 Sanofi Immunological Agents Introduction

11.12.4 Sanofi Revenue in Immunological Agents Business (2019-2024)

11.12.5 Sanofi Recent Development

11.13 Leading Pharma

11.13.1 Leading Pharma Company Detail

11.13.2 Leading Pharma Business Overview

11.13.3 Leading Pharma Immunological Agents Introduction

11.13.4 Leading Pharma Revenue in Immunological Agents Business (2019-2024)

11.13.5 Leading Pharma Recent Development

11.14 Accord Healthcare Inc

11.14.1 Accord Healthcare Inc Company Detail

11.14.2 Accord Healthcare Inc Business Overview

11.14.3 Accord Healthcare Inc Immunological Agents Introduction

11.14.4 Accord Healthcare Inc Revenue in Immunological Agents Business (2019-2024)

11.14.5 Accord Healthcare Inc Recent Development

11.15 Amgen

11.15.1 Amgen Company Detail

11.15.2 Amgen Business Overview

11.15.3 Amgen Immunological Agents Introduction

11.15.4 Amgen Revenue in Immunological Agents Business (2019-2024)

11.15.5 Amgen Recent Development

11.16 Nabi Biopharmaceuticals

11.16.1 Nabi Biopharmaceuticals Company Detail

11.16.2 Nabi Biopharmaceuticals Business Overview

11.16.3 Nabi Biopharmaceuticals Immunological Agents Introduction

11.16.4 Nabi Biopharmaceuticals Revenue in Immunological Agents Business (2019-2024)

11.16.5 Nabi Biopharmaceuticals Recent Development

11.17 Ascend Laboratories

11.17.1 Ascend Laboratories Company Detail

11.17.2 Ascend Laboratories Business Overview

11.17.3 Ascend Laboratories Immunological Agents Introduction

11.17.4 Ascend Laboratories Revenue in Immunological Agents Business (2019-2024)

11.17.5 Ascend Laboratories Recent Development

11.18 Camber Pharmaceuticals Inc

11.18.1 Camber Pharmaceuticals Inc Company Detail

11.18.2 Camber Pharmaceuticals Inc Business Overview

11.18.3 Camber Pharmaceuticals Inc Immunological Agents Introduction

11.18.4 Camber Pharmaceuticals Inc Revenue in Immunological Agents Business (2019-2024)

11.18.5 Camber Pharmaceuticals Inc Recent Development

11.19 Grifols USA

11.19.1 Grifols USA Company Detail

11.19.2 Grifols USA Business Overview

11.19.3 Grifols USA Immunological Agents Introduction

11.19.4 Grifols USA Revenue in Immunological Agents Business (2019-2024)

11.19.5 Grifols USA Recent Development

11.20 JOM Pharmaceuticals

11.20.1 JOM Pharmaceuticals Company Detail

11.20.2 JOM Pharmaceuticals Business Overview

11.20.3 JOM Pharmaceuticals Immunological Agents Introduction

11.20.4 JOM Pharmaceuticals Revenue in Immunological Agents Business (2019-2024)

11.20.5 JOM Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott

Organon

Amneal Pharmaceuticals

Apotex

Teva Pharmaceuticals

Biocon Ltd.

Bristol–Myers Squibb

Merck

CSL Behring

Sanofi

Leading Pharma

Accord Healthcare Inc.

Amgen Inc

Nabi Biopharmaceuticals

Ascend Laboratories

Camber Pharmaceuticals, Inc.

Grifols USA

JOM Pharmaceuticals

List of Tables

Table 1. Global Immunological Agents Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Antirheumatic Drugs (DMARDs)

Table 3. Key Players of Immune Globulins

Table 4. Key Players of Immunomodulatory Agents

Table 5. Key Players of Immunosuppressive Agents

Table 6. Key Players of Monoclonal Antibodies

Table 7. Key Players of Other

Table 8. Global Immunological Agents Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Immunological Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Immunological Agents Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Immunological Agents Market Share by Region (2019-2024)

Table 12. Global Immunological Agents Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Immunological Agents Market Share by Region (2025-2030)

Table 14. Immunological Agents Market Trends

Table 15. Immunological Agents Market Drivers

Table 16. Immunological Agents Market Challenges

Table 17. Immunological Agents Market Restraints

Table 18. Global Immunological Agents Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Immunological Agents Market Share by Players (2019-2024)

Table 20. Global Top Immunological Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunological Agents as of 2023)

Table 21. Ranking of Global Top Immunological Agents Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Immunological Agents Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Immunological Agents Product Solution and Service

Table 25. Date of Enter into Immunological Agents Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Immunological Agents Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Immunological Agents Revenue Market Share by Type (2019-2024)

Table 29. Global Immunological Agents Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Immunological Agents Revenue Market Share by Type (2025-2030)

Table 31. Global Immunological Agents Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Immunological Agents Revenue Market Share by Application (2019-2024)

Table 33. Global Immunological Agents Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Immunological Agents Revenue Market Share by Application (2025-2030)

Table 35. North America Immunological Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Immunological Agents Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Immunological Agents Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Immunological Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Immunological Agents Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Immunological Agents Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Immunological Agents Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Immunological Agents Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Immunological Agents Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Immunological Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Immunological Agents Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Immunological Agents Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Immunological Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Immunological Agents Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Immunological Agents Market Size by Country (2025-2030) & (US$ Million)

Table 50. Abbott Company Detail

Table 51. Abbott Business Overview

Table 52. Abbott Immunological Agents Product

Table 53. Abbott Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 54. Abbott Recent Development

Table 55. Organon Company Detail

Table 56. Organon Business Overview

Table 57. Organon Immunological Agents Product

Table 58. Organon Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 59. Organon Recent Development

Table 60. Pfizer Company Detail

Table 61. Pfizer Business Overview

Table 62. Pfizer Immunological Agents Product

Table 63. Pfizer Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 64. Pfizer Recent Development

Table 65. Sandoz Company Detail

Table 66. Sandoz Business Overview

Table 67. Sandoz Immunological Agents Product

Table 68. Sandoz Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 69. Sandoz Recent Development

Table 70. Amneal Pharmaceuticals Company Detail

Table 71. Amneal Pharmaceuticals Business Overview

Table 72. Amneal Pharmaceuticals Immunological Agents Product

Table 73. Amneal Pharmaceuticals Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 74. Amneal Pharmaceuticals Recent Development

Table 75. Apotex Company Detail

Table 76. Apotex Business Overview

Table 77. Apotex Immunological Agents Product

Table 78. Apotex Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 79. Apotex Recent Development

Table 80. Teva Pharmaceuticals Company Detail

Table 81. Teva Pharmaceuticals Business Overview

Table 82. Teva Pharmaceuticals Immunological Agents Product

Table 83. Teva Pharmaceuticals Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 84. Teva Pharmaceuticals Recent Development

Table 85. Biocon Company Detail

Table 86. Biocon Business Overview

Table 87. Biocon Immunological Agents Product

Table 88. Biocon Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 89. Biocon Recent Development

Table 90. Bristol Myers Squibb Company Detail

Table 91. Bristol Myers Squibb Business Overview

Table 92. Bristol Myers Squibb Immunological Agents Product

Table 93. Bristol Myers Squibb Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 94. Bristol Myers Squibb Recent Development

Table 95. Merck Company Detail

Table 96. Merck Business Overview

Table 97. Merck Immunological Agents Product

Table 98. Merck Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 99. Merck Recent Development

Table 100. CSL Behring Company Detail

Table 101. CSL Behring Business Overview

Table 102. CSL Behring Immunological Agents Product

Table 103. CSL Behring Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 104. CSL Behring Recent Development

Table 105. Sanofi Company Detail

Table 106. Sanofi Business Overview

Table 107. Sanofi Immunological Agents Product

Table 108. Sanofi Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 109. Sanofi Recent Development

Table 110. Leading Pharma Company Detail

Table 111. Leading Pharma Business Overview

Table 112. Leading Pharma Immunological Agents Product

Table 113. Leading Pharma Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 114. Leading Pharma Recent Development

Table 115. Accord Healthcare Inc Company Detail

Table 116. Accord Healthcare Inc Business Overview

Table 117. Accord Healthcare Inc Immunological Agents Product

Table 118. Accord Healthcare Inc Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 119. Accord Healthcare Inc Recent Development

Table 120. Amgen Company Detail

Table 121. Amgen Business Overview

Table 122. Amgen Immunological Agents Product

Table 123. Amgen Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 124. Amgen Recent Development

Table 125. Nabi Biopharmaceuticals Company Detail

Table 126. Nabi Biopharmaceuticals Business Overview

Table 127. Nabi Biopharmaceuticals Immunological Agents Product

Table 128. Nabi Biopharmaceuticals Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 129. Nabi Biopharmaceuticals Recent Development

Table 130. Ascend Laboratories Company Detail

Table 131. Ascend Laboratories Business Overview

Table 132. Ascend Laboratories Immunological Agents Product

Table 133. Ascend Laboratories Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 134. Ascend Laboratories Recent Development

Table 135. Camber Pharmaceuticals Inc Company Detail

Table 136. Camber Pharmaceuticals Inc Business Overview

Table 137. Camber Pharmaceuticals Inc Immunological Agents Product

Table 138. Camber Pharmaceuticals Inc Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 139. Camber Pharmaceuticals Inc Recent Development

Table 140. Grifols USA Company Detail

Table 141. Grifols USA Business Overview

Table 142. Grifols USA Immunological Agents Product

Table 143. Grifols USA Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 144. Grifols USA Recent Development

Table 145. JOM Pharmaceuticals Company Detail

Table 146. JOM Pharmaceuticals Business Overview

Table 147. JOM Pharmaceuticals Immunological Agents Product

Table 148. JOM Pharmaceuticals Revenue in Immunological Agents Business (2019-2024) & (US$ Million)

Table 149. JOM Pharmaceuticals Recent Development

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Immunological Agents Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Immunological Agents Market Share by Type: 2023 VS 2030

Figure 3. Antirheumatic Drugs (DMARDs) Features

Figure 4. Immune Globulins Features

Figure 5. Immunomodulatory Agents Features

Figure 6. Immunosuppressive Agents Features

Figure 7. Monoclonal Antibodies Features

Figure 8. Other Features

Figure 9. Global Immunological Agents Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Immunological Agents Market Share by Application: 2023 VS 2030

Figure 11. Hospital Case Studies

Figure 12. Clinics Case Studies

Figure 13. Others Case Studies

Figure 14. Immunological Agents Report Years Considered

Figure 15. Global Immunological Agents Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Immunological Agents Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Immunological Agents Market Share by Region: 2023 VS 2030

Figure 18. Global Immunological Agents Market Share by Players in 2023

Figure 19. Global Top Immunological Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunological Agents as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Immunological Agents Revenue in 2023

Figure 21. North America Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Immunological Agents Market Share by Country (2019-2030)

Figure 23. United States Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Immunological Agents Market Share by Country (2019-2030)

Figure 27. Germany Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Immunological Agents Market Share by Region (2019-2030)

Figure 35. China Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Immunological Agents Market Share by Country (2019-2030)

Figure 43. Mexico Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Immunological Agents Market Share by Country (2019-2030)

Figure 47. Turkey Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Immunological Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Abbott Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 50. Organon Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 51. Pfizer Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 52. Sandoz Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 53. Amneal Pharmaceuticals Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 54. Apotex Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 55. Teva Pharmaceuticals Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 56. Biocon Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 57. Bristol Myers Squibb Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 58. Merck Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 59. CSL Behring Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 60. Sanofi Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 61. Leading Pharma Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 62. Accord Healthcare Inc Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 63. Amgen Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 64. Nabi Biopharmaceuticals Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 65. Ascend Laboratories Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 66. Camber Pharmaceuticals Inc Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 67. Grifols USA Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 68. JOM Pharmaceuticals Revenue Growth Rate in Immunological Agents Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Immune Adjuvant Market Research Report 2024

Global Neutralizing Agent Market Research Report 2025

Global Health Product for Immune Market Research Report 2024

Global Biological Agent Detector Market Research Report 2024

Global Anti herpesvirus Agent Market Research Report 2025

Global IHC Antibody Market Research Report 2024

Global Sanitizing Agents Market Research Report 2024

Global Antibodies Market Research Report 2024

Global Immuno Oncology Treatment Market Insights Forecast to 2030

Global Sunscreening Agents Market Research Report 2024

Global Alkylating Agents Market Research Report 2024

Global Glazing Agents Market Research Report 2024

Biosimilar Drug Market

Global Gamma Globulin Therpeautic Agent Market Research Report 2024

Global Human Immunoglobulin Market Research Report 2024

Global Alarm Agents Market Research Report 2025

Global Interface Agents Market Research Report 2024

Global Acaricide Agent Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions